| 0 |
SKIN CANDIDA |
33 |
0.0632 |
| 1 |
MULTIPLE DRUG THERAPY |
30 |
0.0398 |
| 2 |
SEDATION COMPLICATION |
93 |
0.0364 |
| 3 |
CREATININE RENAL CLEARANCE INCREASED |
25 |
0.0334 |
| 4 |
CREATININE RENAL CLEARANCE DECREASED |
105 |
0.0262 |
| 5 |
CEREBRAL CONGESTION |
4 |
0.0238 |
| 6 |
PARATHYROID HYPERPLASIA |
1 |
0.0179 |
| 7 |
HYPERPARATHYROIDISM TERTIARY |
1 |
0.0133 |
| 8 |
AMINO ACID LEVEL ABNORMAL |
1 |
0.0103 |
| 9 |
BLOOD CALCIUM DECREASED |
105 |
0.0093 |
| 10 |
RENAL FUNCTION TEST ABNORMAL |
35 |
0.0075 |
| 11 |
ORTHOSTATIC HYPOTENSION |
114 |
0.0065 |
| 12 |
NEUTROPENIC SEPSIS |
34 |
0.0048 |
| 13 |
ANORECTAL INFECTION |
1 |
0.0040 |
| 14 |
SEDATION |
94 |
0.0036 |
| 15 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
102 |
0.0026 |
| 16 |
HYPOMAGNESAEMIA |
34 |
0.0024 |
| 17 |
BLADDER DISORDER |
23 |
0.0023 |
| 18 |
COGNITIVE DISORDER |
105 |
0.0022 |
| 19 |
CHONDROLYSIS |
1 |
0.0021 |
| 20 |
HYPERAEMIA |
4 |
0.0020 |
| 21 |
TERMINAL ILEITIS |
1 |
0.0016 |
| 22 |
MOUTH ULCERATION |
33 |
0.0016 |
| 23 |
MOBILITY DECREASED |
111 |
0.0015 |
| 24 |
BALANCE DISORDER |
130 |
0.0015 |
| 25 |
HAND DEFORMITY |
19 |
0.0014 |
| 26 |
HAEMOTHORAX |
4 |
0.0014 |
| 27 |
INHIBITORY DRUG INTERACTION |
2 |
0.0013 |
| 28 |
MUCOSAL INFLAMMATION |
33 |
0.0013 |
| 29 |
SCIATICA |
20 |
0.0013 |
| 30 |
DEFORMITY |
11 |
0.0012 |
| 31 |
CANDIDA INFECTION |
19 |
0.0011 |
| 32 |
CONJUNCTIVAL HAEMORRHAGE |
4 |
0.0010 |
| 33 |
ANIMAL SCRATCH |
1 |
0.0010 |
| 34 |
CARDIOPULMONARY FAILURE |
4 |
0.0010 |
| 35 |
NERVOUS SYSTEM DISORDER |
30 |
0.0010 |
| 36 |
ISCHAEMIC CEREBRAL INFARCTION |
1 |
0.0009 |
| 37 |
PANCREATITIS CHRONIC |
2 |
0.0008 |
| 38 |
LIP HAEMORRHAGE |
1 |
0.0008 |
| 39 |
PLATELET TRANSFUSION |
1 |
0.0008 |
| 40 |
HYPOKALAEMIA |
34 |
0.0007 |
| 41 |
NEUTROPHIL COUNT DECREASED |
30 |
0.0007 |
| 42 |
PRODUCTIVE COUGH |
33 |
0.0007 |
| 43 |
CONTRAINDICATED PRODUCT ADMINISTERED |
19 |
0.0006 |
| 44 |
CONSTIPATION |
136 |
0.0006 |
| 45 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 46 |
TOXICITY TO VARIOUS AGENTS |
79 |
0.0005 |
| 47 |
DEMENTIA |
13 |
0.0005 |
| 48 |
HYPOTENSION |
93 |
0.0005 |
| 49 |
ARTERIOSCLEROSIS |
4 |
0.0004 |
| 50 |
HYPERPARATHYROIDISM SECONDARY |
1 |
0.0004 |
| 51 |
ORAL CANDIDIASIS |
5 |
0.0004 |
| 52 |
DRUG ABUSE |
31 |
0.0004 |
| 53 |
METASTASES TO BONE |
6 |
0.0004 |
| 54 |
PERIPHERAL COLDNESS |
5 |
0.0004 |
| 55 |
DYSPHAGIA |
33 |
0.0003 |
| 56 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 57 |
BRAIN OEDEMA |
4 |
0.0003 |
| 58 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 59 |
PULMONARY CONGESTION |
4 |
0.0003 |
| 60 |
CYTOKINE RELEASE SYNDROME |
6 |
0.0003 |
| 61 |
FALL |
99 |
0.0003 |
| 62 |
GAIT DISTURBANCE |
56 |
0.0003 |
| 63 |
INJECTION SITE REACTION |
19 |
0.0003 |
| 64 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 65 |
DRUG INTERACTION |
43 |
0.0003 |
| 66 |
MYOCARDIAL ISCHAEMIA |
3 |
0.0003 |
| 67 |
DEHYDRATION |
33 |
0.0002 |
| 68 |
AORTIC DISSECTION |
1 |
0.0002 |
| 69 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 70 |
PRODUCT USE IN UNAPPROVED INDICATION |
57 |
0.0002 |
| 71 |
RHEUMATOID ARTHRITIS |
26 |
0.0002 |
| 72 |
ANAEMIA |
40 |
0.0002 |
| 73 |
RASH VESICULAR |
1 |
0.0002 |
| 74 |
AGEUSIA |
5 |
0.0002 |
| 75 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 76 |
TREATMENT FAILURE |
15 |
0.0002 |
| 77 |
PAIN |
110 |
0.0002 |
| 78 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 79 |
ENTEROCOLITIS |
1 |
0.0002 |
| 80 |
POISONING |
2 |
0.0002 |
| 81 |
DYSPNOEA |
88 |
0.0002 |
| 82 |
DECREASED APPETITE |
36 |
0.0002 |
| 83 |
OVERDOSE |
33 |
0.0002 |
| 84 |
DEPRESSION |
32 |
0.0001 |
| 85 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 86 |
PREMATURE DELIVERY |
2 |
0.0001 |
| 87 |
HEMIPLEGIA |
1 |
0.0001 |
| 88 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 89 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 90 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 91 |
WOUND INFECTION |
1 |
0.0001 |
| 92 |
ASTHENIA |
34 |
0.0001 |
| 93 |
PULMONARY OEDEMA |
4 |
0.0001 |
| 94 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 95 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
4 |
0.0001 |
| 96 |
DRUG INTOLERANCE |
8 |
0.0001 |
| 97 |
HEPATIC CYTOLYSIS |
1 |
0.0001 |
| 98 |
HEPATITIS |
2 |
0.0001 |
| 99 |
VOMITING |
36 |
0.0001 |
| 100 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 101 |
OEDEMA |
4 |
0.0001 |
| 102 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 103 |
CONDITION AGGRAVATED |
22 |
0.0001 |
| 104 |
ARTHROPATHY |
4 |
0.0001 |
| 105 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 106 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 107 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 108 |
OSTEOPENIA |
1 |
0.0001 |
| 109 |
ILL-DEFINED DISORDER |
4 |
0.0001 |
| 110 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 111 |
VISUAL IMPAIRMENT |
8 |
0.0001 |
| 112 |
PRODUCT USE ISSUE |
12 |
0.0001 |
| 113 |
CONTUSION |
6 |
0.0001 |
| 114 |
COMPLETED SUICIDE |
5 |
0.0001 |
| 115 |
HEADACHE |
37 |
0.0001 |
| 116 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 117 |
HYPOXIA |
2 |
0.0001 |
| 118 |
DIARRHOEA |
36 |
0.0001 |
| 119 |
BONE DISORDER |
1 |
0.0001 |
| 120 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 121 |
OFF LABEL USE |
48 |
0.0001 |
| 122 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 123 |
NAUSEA |
40 |
0.0001 |
| 124 |
CARDIAC FAILURE |
4 |
0.0000 |
| 125 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 126 |
HYPOAESTHESIA |
7 |
0.0000 |
| 127 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 128 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 129 |
DEATH |
37 |
0.0000 |
| 130 |
SWELLING |
4 |
0.0000 |
| 131 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 132 |
SOMNOLENCE |
8 |
0.0000 |
| 133 |
ANHEDONIA |
1 |
0.0000 |
| 134 |
NEUTROPENIA |
5 |
0.0000 |
| 135 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 136 |
BONE PAIN |
2 |
0.0000 |
| 137 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 138 |
FEMUR FRACTURE |
1 |
0.0000 |
| 139 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 140 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 141 |
ALOPECIA |
6 |
0.0000 |
| 142 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 143 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 144 |
LIP SWELLING |
1 |
0.0000 |
| 145 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 146 |
HYPERKALAEMIA |
1 |
0.0000 |
| 147 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 148 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 149 |
CHILLS |
3 |
0.0000 |
| 150 |
BLINDNESS |
1 |
0.0000 |
| 151 |
ERYTHEMA |
5 |
0.0000 |
| 152 |
OSTEOPOROSIS |
1 |
0.0000 |
| 153 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 154 |
HYPOACUSIS |
1 |
0.0000 |
| 155 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 156 |
INSOMNIA |
6 |
0.0000 |
| 157 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 158 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 159 |
DRUG INEFFECTIVE |
28 |
0.0000 |
| 160 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 161 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 162 |
PAIN IN EXTREMITY |
6 |
0.0000 |
| 163 |
BRADYCARDIA |
1 |
0.0000 |
| 164 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 165 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 166 |
PANCYTOPENIA |
1 |
0.0000 |
| 167 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 168 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 169 |
STOMATITIS |
1 |
0.0000 |
| 170 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 171 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 172 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 173 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 174 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 175 |
INJURY |
1 |
0.0000 |
| 176 |
FATIGUE |
11 |
0.0000 |
| 177 |
EPISTAXIS |
1 |
0.0000 |
| 178 |
HOT FLUSH |
1 |
0.0000 |
| 179 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 180 |
ARTHRITIS |
1 |
0.0000 |
| 181 |
CARDIAC ARREST |
1 |
0.0000 |
| 182 |
TREMOR |
2 |
0.0000 |
| 183 |
DIZZINESS |
6 |
0.0000 |
| 184 |
MALAISE |
5 |
0.0000 |
| 185 |
TACHYCARDIA |
1 |
0.0000 |
| 186 |
ADVERSE EVENT |
1 |
0.0000 |
| 187 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 188 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 189 |
FLUSHING |
1 |
0.0000 |
| 190 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 191 |
SEPSIS |
1 |
0.0000 |
| 192 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 193 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 194 |
JOINT SWELLING |
1 |
0.0000 |
| 195 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 196 |
RENAL FAILURE |
1 |
0.0000 |
| 197 |
INFECTION |
1 |
0.0000 |
| 198 |
HOSPITALISATION |
1 |
0.0000 |
| 199 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 200 |
URTICARIA |
1 |
0.0000 |
| 201 |
COVID-19 |
1 |
0.0000 |
| 202 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 203 |
BACK PAIN |
1 |
0.0000 |
| 204 |
WEIGHT DECREASED |
1 |
0.0000 |
| 205 |
COUGH |
1 |
0.0000 |
| 206 |
ANXIETY |
1 |
0.0000 |
| 207 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 208 |
PNEUMONIA |
1 |
0.0000 |
| 209 |
PYREXIA |
1 |
0.0000 |
| 210 |
PRURITUS |
1 |
0.0000 |